Pricing Log in Create free account
Friday 6 November 2026 Export TECH’s income statement to Excel — free account

Bio-Techne Corp

TECH Healthcare Biotechnology

Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025.

Revenue
+4.59%
EPS
−28.0%
Free cash flow
+202.4%
Total debt
−42.2%

Quarter to September 2026, against a year earlier

72.79 0.13 +0.18%
Market cap
$11.4B
P/E
66.2×
Fwd P/E
54.2×
Dividend yield
0.44%
F-score
9/9
Altman Z
15.50
Beneish M
−2.52
Dividend safety
78/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Bio-Techne Corp 10-Q filed May 8, 2025

Fiscal Q3 2025 · Period ended Mar 31, 2025 · Filed · accepted 4:30 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors, against the 10-Q filed Feb 6, 2025: no comparison — the earlier filing's Item cannot be compared